Galderma Group AG
GALD
Rank in Stocks
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Share Price
$224.81
Market Cap
$52.42B
Change (1 day)
6.31%
Change (1 year)
31.28%
Country
CH
Trade Galderma Group AG (GALD)
Category
Healthcare
Earnings for Galderma Group AG (GALD)
Earnings in 2026 TTM: 0
According to Galderma Group AG latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Galderma Group AG from 2021 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2025 | $638.00M | 86.91% |
| 2024 | $341.33M | 3,003.04% |
| 2023 | $11.00M | -120.52% |
| 2022 | $-53.59M | -32.74% |
| 2021 | $-79.68M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
